このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Qungasvik (Toolbox)-Healthy Hearts: A Cultural Approach to Reducing Chronic Disease Risk (AK CEAL EI)

2026年9月15日 更新者:University of Alaska Fairbanks

Qungasvik (Toolbox)-Healthy Hearts: An Alaska Enrichment Initiative (AK Enrichment)

Due to the extreme remoteness, transportation challenges, and lack of access to clinical care, the delivery of preventative health interventions in rural Alaska Native communities is a top tribal priority. Chronic disease and behavioral health contribute to the higher rates of mortality and morbidity experienced in rural Alaska. This study will test the effectiveness of a culturally-grounded, community-delivered preventive intervention, Qungasvik-Healthy Hearts, to reduce risk factors associated with chronic disease and behavioral health in three rural Alaska Native communities. Implementation science outcomes will identify key contextual factors, social determinants and costs associated with health outcomes related to positive change in behavior, blood pressure, diet and physical activity, assessed among 300 participants from the three rural communities.

調査の概要

詳細な説明

Chronic disease is a primary contributor to mortality in the US, and while rates are rising in all populations, AIAN people remain disproportionately burdened. The remoteness and lack of acute care in rural Alaska Native (AN) communities, means that cardiovascular and cerebrovascular events are more likely to be catastrophic and have lower survivorship and recovery outcomes. Due to the remoteness, transportation challenges, and lack of access to medicine and healthcare, preventative health for chronic disease in rural AN communities is of utmost concern. During Phase I of the American Indian, Alaska Native, Native Hawaiian, Pacific Islander (AIAN NHPI) Enrichment Initiative, our Alaska site conducted a pilot implementation of the adapted culturally-grounded and evidence-based intervention known as Qungasvik-Healthy Hearts to assess feasibility and acceptability, as well as preliminary impact on cerebrovascular and cardiovascular disease risk in one rural AN community. The AK Enrichment Phase II project will expand the study in an effectiveness implementation hybrid type 1 trial conducted in three additional rural AN communities utilizing a dynamic waitlisted design (DWLD). Phase II will test intervention impacts with 300 individuals to determine clinical outcomes, including diet measured by nitrogen isotope ratios in hair, physical activity intensity and duration, social connectedness, and blood pressure, all primary risk and protective factors for chronic disease. The study has an intergenerational focus, addressing chronic disease prevention across the lifespan with an emphasis on young people's health and well-being in connection with older adults whose health and well-being is interdependent and connected to their transmission of cultural knowledge and subsistence practices to the upcoming generations of AN people. The primary goal will be to assess the culturally-grounded intervention's impact on the clinical outcome variables of cardiovascular and cerebrovascular disease risk factors, including traditional Yup'ik diet measured through nitrogen isotope ratios in hair, physical activity intensity and duration, social connectedness, and blood pressure.

研究の種類

介入

入学 (推定)

300

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

研究場所

    • Alaska
      • Fairbanks、Alaska、アメリカ、99775
        • University of Alaska Fairbanks
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

12年歳以上 (子、大人、高齢者)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria:

  • self-identify as a permanent resident of the study community
  • be a youth between the ages of 12-17 years, a young adult between the ages of 18-24, or an adult or elder the ages of 45+
  • be able to provide written informed consent.

Exclusion Criteria:

  • does not have permanent residence in the community
  • is unable to provide written informed consent. All participant-facing study materials will be provided at an eighth-grade reading level.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:なし
  • 介入モデル:単一グループの割り当て
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Implement Qungasvik-Healthy Hearts 12-month community-based preventive intervention

Implementation of Qungasvik-Healthy Hearts intervention over a 12-month period of delivery. A local Community Planning Group (CPG) facilitates 18-24 activities tailored to directly address upstream cerebrovascular and cardiovascular disease risk factors, by supporting youth and older adults to increase intensity and duration of physical activity, facilitate social support and connection, and increase intake of traditional Yup'ik foods. These activities included modules such as Yuraq (traditional Yup'ik dance), moose hunting, ice fishing, and gathering (greens, eggs, etc.) on the land.

Qungasvik-Healthy Hearts preventive intervention is a novel adaptation of an evidence-based practice that was developed by Yup'ik AN communities to address mental health and alcohol misuse. Qungasvik-Healthy Hearts explores the broader association between revitalizing physically laborious, socially connecting, and nutritionally rich traditional Yup'ik practices like hunting, gathering, and fishing, with cerebrovascular and cardiovascular disease risk reduction. A local Community Planning Group (CPG) facilitates activities tailored to directly address upstream cerebrovascular and cardiovascular disease risk factors, by supporting youth and older adults to increase intensity and duration of physical activity, facilitate social support and connection, and increase intake of traditional Yup'ik foods. These activities included modules such as Yuraq (traditional Yup'ik dance), moose hunting, ice fishing, and gathering (greens, eggs, etc.) on the land.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
ActiGraph accelerometer data will measure the intensity of daily activity that we hypothesize will go up with intervention participation.
時間枠:Day 1 Baseline(B) and 12-month follow-up (T2)

Physical activity will be objectively measured using an ActiGraph accelerometer, a validated wearable device that provides reliable estimates of free-living physical activity. Participants will wear the device for the prescribed monitoring period to capture movement continuously throughout daily activities. Accelerometer data will be processed using established protocols to estimate daily minutes of moderate-to-vigorous physical activity. Objective accelerometer data will complement self-reported measures of physical activity by reducing recall bias and providing precise estimates of changes in activity patterns over time.

Day 1 Baseline(B) and 12-month follow-up (T2)
Traditional Food Intake
時間枠:Points of Assessment: Baseline(B) and 12-month follow-up (T2)

Traditional food intake will be assessed using both a self-reported dietary survey and hair nitrogen stable isotope ratio (¹⁵N/¹⁴N; δ¹⁵N) analysis. The dietary survey will capture the frequency and types of traditional foods consumed, providing information on dietary patterns and subsistence food practices. Hair samples will be collected to measure δ¹⁵N, a validated, objective biomarker of long-term traditional marine food intake among Alaska Native populations. Because hair integrates dietary intake over several months, δ¹⁵N provides a reliable estimate of sustained consumption of traditional subsistence foods, particularly marine fish and mammals, and is not subject to recall or social desirability bias. The combined use of self-reported dietary intake and the objective biomarker will strengthen the assessment of intervention-related changes in traditional food consumption by capturing both perceived dietary behaviors and biologically verified intake. These complementary measures

Points of Assessment: Baseline(B) and 12-month follow-up (T2)
Blood Pressure
時間枠:Points of Assessment: Baseline(B), 6-month intervention midpoint(T1), and 12-month follow-up (T2)

Blood pressure will be measured as an objective indicator of cardiovascular health and a key physiological outcome of the intervention. Systolic and diastolic blood pressure will be assessed using standardized protocols via Omron digital blood pressure monitor, including appropriate participant positioning, rest periods prior to measurement, and repeated readings to improve reliability. Primary outcomes will include changes in systolic blood pressure, diastolic blood pressure, and blood pressure categories over time. These measures will be used to evaluate whether participation in the intervention contributes to improvements in cardiovascular health through hypothesized pathways involving increased physical activity, improved dietary practices, reduced stress, and strengthened social and cultural connectedness.

Points of Assessment: Baseline(B), 6-month intervention midpoint(T1), and 12-month follow-up (T2)
We will assess how intervention participation increases social and cultural connectedness using the Awareness of Connectedness Scale.
時間枠:Points of Assessment: Baseline(B), 6-month intervention midpoint(T1), and 12-month follow-up (T2)

The Awareness of Connectedness Scale (ACS), developed by Mohatt and Fok, measures an individual's awareness of their interrelatedness with family, community, and the natural environment. This scale is particularly focused on cultural aspects of wellness and healing among Alaska Native people, providing insights into their social and ecological connections. We will utilize data from the scale to assess the intervention impacts on building connectedness among individual participants.

Points of Assessment: Baseline(B), 6-month intervention midpoint(T1), and 12-month follow-up (T2)
ActiGraph accelerometer data will measure the frequency of daily activity that we hypothesize will go up with intervention participation.
時間枠:Day 1 Baseline, 12 months

Physical activity will be objectively measured using an ActiGraph accelerometer, a validated wearable device that provides reliable estimates of free-living physical activity. Participants will wear the device for the prescribed monitoring period to capture movement continuously throughout daily activities. Accelerometer data will be processed using established protocols to estimate daily minutes of physical activity. Objective accelerometer data will complement self-reported measures of physical activity by reducing recall bias and providing precise estimates of changes in activity patterns over time.

Day 1 Baseline, 12 months
ActiGraph accelerometer data will measure the duration of daily activity including time spent in sedentary, light, moderate, and vigorous activity.
時間枠:Day 1 Baseline, 12 months post follow-up

Physical activity will be objectively measured using an ActiGraph accelerometer, a validated wearable device that provides reliable estimates of free-living physical activity. Participants will wear the device for the prescribed monitoring period to capture movement continuously throughout daily activities. Accelerometer data will be processed using established protocols to estimate sedentary time and step counts. Objective accelerometer data will complement self-reported measures of physical activity by reducing recall bias and providing precise estimates of changes in activity patterns over time.

Day 1 Baseline, 12 months post follow-up
We will assess how the intervention increases individual protective factors using the Multi-Cultural Mastery Scale
時間枠:Day 1 Baseline, 6 months, 12 months

The Multicultural Mastery Scale, developed by Allen and Mohatt, assesses coping strategies through self-mastery and communal mastery dimensions. It includes subscales that differentiate between mastery related to family and friends, highlighting the importance of social networks. We will utilize data from this scale to determine how the intervention increases positive coping and builds social networks connections in individuals who participate.

Day 1 Baseline, 6 months, 12 months
We will assess how the intervention increases reasons for life and meaning and purpose using the Reasons for Life Scale
時間枠:Day 1 baseline, 6 months, 12 months

The Reasons for Life Scale (RFL), developed by Allen and Rasmus, focuses on cultural strengths and protective factors against suicide, particularly among Alaska Native people. It emphasizes resilience, cultural teachings, and community recognition as vital components in promoting mental health and preventing suicide. We will utilize data from scale to assess how the intervention promotes reasons for life and associates with mental health outcomes (depression and anxiety) in individuals who participate in activities.

Day 1 baseline, 6 months, 12 months
We will assess social support using the Multidimensional Scale of Perceived Social Support (MSPSS).
時間枠:Day 1, 6 months, 12 months

The Multidimensional Scale of Perceived Social Support (MSPSS) is a 12-item questionnaire to identify an individual's perceived level of social support with family, friends, and significant others.

Day 1, 6 months, 12 months
We will assess social connection through a self-report measure of intergenerational interaction and social engagement that we hypothesize will increase with intervention participation.
時間枠:Day 1, 6 months, 12 months

This self-report measure is generated by an Alaska Native community advisory board and is tailored to a rural Alaska Native community including items assessing interaction with Elders and engagement in community gatherings.

Day 1, 6 months, 12 months

二次結果の測定

結果測定
メジャーの説明
時間枠
Food Security
時間枠:Points of Assessment: Baseline(B), 6-month intervention midpoint(T1), and 12-month follow-up (T2)

Validated behavioral survey measure: NIH PROMIS

Points of Assessment: Baseline(B), 6-month intervention midpoint(T1), and 12-month follow-up (T2)
Reasons for Life
時間枠:Points of Assessment: Baseline(B), 6-month intervention midpoint(T1), and 12-month follow-up (T2)

Validated behavioral survey measure for mental health

Points of Assessment: Baseline(B), 6-month intervention midpoint(T1), and 12-month follow-up (T2)
Global Health
時間枠:Points of Assessment: Baseline(B), 6-month intervention midpoint(T1), and 12-month follow-up (T2)

Validated behavioral survey measure PhenX Toolkit

Points of Assessment: Baseline(B), 6-month intervention midpoint(T1), and 12-month follow-up (T2)
We will assess if food security increases using the food security index from the PhenX Toolkit
時間枠:Day 1 Baseline, 6 months, 12 months

The PhenX Toolkit includes standardized measures for assessing food security, which is crucial for understanding social determinants of health. We will use items from the standardized food security tools to evaluate how food access impacts health outcomes and if food security increases with individual participation in the intervention.

Day 1 Baseline, 6 months, 12 months
We will assess how the intervention impacts physical activity by using a set of questions developed by our community partners to determine how people's physical activity behaviors might have changed with the intervention.
時間枠:Day 1, 6 months, 12 months

We include a self-report measure of physical activity that is tailored to normative activities that people engage in rural Alaska Native communities including asking about daily, activities such as walking, cleaning the house, cooking food, fixing a vehicle, chopping wood, processing game, etc.

Day 1, 6 months, 12 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Stacy Rasmus, PhD、University of Alaska Fairbanks
  • 主任研究者:Jennifer Shaw、University of Alaska Fairbanks

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年10月1日

一次修了 (推定)

2028年12月1日

研究の完了 (推定)

2029年1月1日

試験登録日

最初に提出

2026年8月26日

QC基準を満たした最初の提出物

2026年9月15日

最初の投稿 (実際)

2026年9月21日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月21日

QC基準を満たした最後の更新が送信されました

2026年9月15日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する